Literature DB >> 8083732

Differential expression of synaptic vesicle protein 2 (SV2) isoforms.

S M Bajjalieh1, G D Frantz, J M Weimann, S K McConnell, R H Scheller.   

Abstract

The synaptic vesicle proteins SV2A and SV2B (SV2 = synaptic vesicle protein 2) are two highly related proteins belonging to a family of transporters. As a first step toward identifying the function of the SV2 proteins, we examined the expression of SV2A and SV2B in the rat brain by in situ hybridization, immunohistochemistry, and immunoprecipitation with isoform-specific antibodies. These analyses revealed that one isoform, SV2A, is expressed ubiquitously throughout the brain at varying levels. The other isoform, SV2B, has a more limited distribution with varying degrees of coexpression with SV2A. Immunoprecipitation of brain synaptic vesicles with isoform-specific antibodies followed by Western analyses suggests that both isoforms can be present on the same synaptic vesicle. The expression of the SV2 proteins did not correlate either with neurotransmitter phenotype or with the expression of other synaptic vesicle protein isoforms. SV2B expression was observed to change during development; it is more widely expressed in the immature brain and is found in cells that have yet to establish synaptic contacts. The ubiquitous and overlapping expression of the SV2s suggests that they perform a function common to all synaptic vesicles. Variable and changing coexpression of the SV2 isoforms may indicate that SV2 function is regulated by the isoform composition of synaptic vesicles. The observation that the synaptic vesicle proteins, all occurring in multiple isoforms, are differentially expressed with respect to each other indicates that up to 90 different vesicle types are possible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083732      PMCID: PMC6577109     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  127 in total

Review 1.  Synaptic vesicle proteins and neuronal plasticity in adrenergic neurons.

Authors:  X E Hou; A Dahlström
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.

Authors:  Elissa Yozawitz; Arthur Stacey; Ronit M Pressler
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

3.  Synaptic vesicle protein 2, A new neuroendocrine cell marker.

Authors:  G M Portela-Gomes; A Lukinius; L Grimelius
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  A high-throughput method for generating uniform microislands for autaptic neuronal cultures.

Authors:  Allyson E Sgro; Amy L Nowak; Naola S Austin; Kenneth L Custer; Peter B Allen; Daniel T Chiu; Sandra M Bajjalieh
Journal:  J Neurosci Methods       Date:  2011-04-14       Impact factor: 2.390

5.  Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates.

Authors:  Songye Li; Zhengxin Cai; Xiaoai Wu; Daniel Holden; Richard Pracitto; Michael Kapinos; Hong Gao; David Labaree; Nabeel Nabulsi; Richard E Carson; Yiyun Huang
Journal:  ACS Chem Neurosci       Date:  2018-11-16       Impact factor: 4.418

6.  Area postrema undergoes dynamic postnatal changes in mice and humans.

Authors:  Hamza Numan Gokozan; Faisal Baig; Sarah Corcoran; Fay Patsy Catacutan; Patrick Edwin Gygli; Ana C Takakura; Thiago S Moreira; Catherine Czeisler; José J Otero
Journal:  J Comp Neurol       Date:  2015-12-17       Impact factor: 3.215

Review 7.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

8.  Commissural neurons in the rat ventral cochlear nucleus.

Authors:  John R Doucet; Nicole M Lenihan; Bradford J May
Journal:  J Assoc Res Otolaryngol       Date:  2009-01-27

Review 9.  PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.

Authors:  Zhengxin Cai; Songye Li; David Matuskey; Nabeel Nabulsi; Yiyun Huang
Journal:  Neurosci Lett       Date:  2018-07-31       Impact factor: 3.046

10.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Authors:  Min Dong; Huisheng Liu; William H Tepp; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.